Trial · NCT00903331
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Forced Vital Capacity (FVC) at Baseline and End of Period 1 | Placebo | Baseline | 2.74 | 95% Confidence Interval 0.776 | litres |
| Forced Vital Capacity (FVC) at Baseline and End of Period 1 | ACT-064922 | Baseline | 2.83 | 95% Confidence Interval 0.834 | litres |
| Forced Vital Capacity (FVC) at Baseline and End of Period 1 | Placebo | End of Period 1 | 2.40 | 95% Confidence Interval 0.918 | litres |
| Forced Vital Capacity (FVC) at Baseline and End of Period 1 | ACT-064922 | End of Period 1 | 2.57 | 95% Confidence Interval 1.012 | litres |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | Placebo | Patients at Risk of Event at Month 4 | 59 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | ACT-064922 | Patients at Risk of Event at Month 4 | 112 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | Placebo | Patients at Risk of Event at Month 8 | 57 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | ACT-064922 | Patients at Risk of Event at Month 8 | 103 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | Placebo | Patients at Risk of Event at Month 12 | 44 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | ACT-064922 | Patients at Risk of Event at Month 12 | 81 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | Placebo | Patients at Risk of Event at Month 16 | 22 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | ACT-064922 | Patients at Risk of Event at Month 16 | 43 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | Placebo | Patients at Risk of Event at Month 20 | 8 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | ACT-064922 | Patients at Risk of Event at Month 20 | 14 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | Placebo | Patients at Risk of Event at Month 24 | 2 | participants | |
| Number of Patients at Risk of Event of Disease Worsening or Death up to the End of Study | ACT-064922 | Patients at Risk of Event at Month 24 | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00903331/results